Teichoic acids (TAs), and especially lipoteichoic acids (LTAs), are one of the main immunostimulatory components of pathogenic Grampositive bacteria. Their contribution to the immunomodulatory properties of commensal bacteria and especially of lactic acid bacteria has not yet been investigated in detail. To evaluate the role of TAs in the interaction between lactic acid bacteria and the immune system, we analyzed the antiinflammatory properties of a mutant of Lactobacillus plantarum NCIMB8826 affected in the TA biosynthesis pathway both in vitro (mononuclear cells stimulation) and in vivo (murine model of colitis). This Dlt(-) mutant was found to incorporate much less D-Ala in its TAs than the WT strain. This defect significantly impacted the immunomodulation reactions induced by the bacterium, as shown by a dramatically reduced secretion of proinflammatory cytokines by peripheral blood mononuclear cells and monocytes stimulated by the Dlt- mutant as compared with the parental strain. Concomitantly, a significant increase in IL-10 production was stimulated by the Dlt(-) mutant in comparison with the WT strain. Moreover, the proinflammatory capacity of L. plantarum-purified LTA was found to be Toll-like receptor 2-dependent. Consistent with the in vitro results, the Dlt(-)mutant was significantly more protective in a murine colitis model than its WT counterpart. The results indicated that composition of LTA within the whole-cell context of L. plantarum can modulate proinflammatory or antiinflammatory immune responses.
DUCHMANN R., KAISER I., HERMANN E., MAYET W., EWE K., BÜSCHENFELDE K.-H. MEYER ZUM, Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD), 10.1111/j.1365-2249.1995.tb03836.x
Mercenier A., Pavan S., Pot B., Probiotics as Biotherapeutic Agents: Present Knowledge and Future Prospects, 10.2174/1381612033392224
Miettinen, Infection and Immunity, 66, 6058 (1998)
HESSLE, HANSON, WOLD, Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production, 10.1046/j.1365-2249.1999.00885.x
Maassen Catharina B.M., van Holten-Neelen Conny, Balk Fräncis, Heijne den Bak-Glashouwer Marie-Joan, Leer Rob J., Laman Jon D., Boersma Wim J.A., Claassen Eric, Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains, 10.1016/s0264-410x(99)00378-3
Viti i, Biocell : official journal of the Sociedades Latinoamericanas de Microscop a Electronica ... et. al, 24, 223 (2000)
Christensen H. R., Frokiaer H., Pestka J. J., Lactobacilli Differentially Modulate Expression of Cytokines and Maturation Surface Markers in Murine Dendritic Cells, 10.4049/jimmunol.168.1.171
Fedorak Richard N., Madsen Karen L., Probiotics and the Management of Inflammatory Bowel Disease : , 10.1097/00054725-200405000-00018
Fabia R., Ar'rajab A., Johansson M. L., Willén R., Andersson R., Molin G., Bengmark S., The Effect of Exogenous Administration ofLactobacillus reuteriR2LC and Oat Fiber on Acetic Acid-Induced Colitis in the Rat, 10.3109/00365529309096063
Mao Y, Nobaek S, Kasravi B, Adawi D, Stenram U, Molin G, Jeppsson B, The effects of Lactobacillus strains and oat fiber on methotrexate- induced enterocolitis in rats, 10.1053/gast.1996.v111.pm8690198
Madsen Karen L., Doyle Jason S., Jewell Laurence D., Tavernini Michele M., Fedorak Richard N., Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice, 10.1016/s0016-5085(99)70013-2
Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon ATR, Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial, 10.1016/s0140-6736(98)06343-0
Gionchetti Paolo, Rizzello Fernando, Venturi Alessandro, Brigidi Patrizia, Matteuzzi Diego, Bazzocchi Gabriele, Poggioli Gilberto, Miglioli Mario, Campieri Massimo, Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial, 10.1053/gast.2000.9370
Mimura T, Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis, 10.1136/gut.53.1.108
Penagini, Gut, 54, 727 (2005)
Mercenier A., Hols P., Roussel Y., Perez-Martinez G., Buesa J., Wilks M., Pozzi G., Remaut E., Morelli L., Grangette C., Monedero V., Palumbo E., Foligne B., Steidler L., Nutten S., Screening and construction of probiotic strains with enhanced protective properties against intestinal disorders, 10.1080/08910600410033258
Schiffrin E.J., Rochat F., Link-Amster H., Aeschlimann J.M., Donnet-Hughes A., Immunomodulation of Human Blood Cells Following the Ingestion of Lactic Acid Bacteria, 10.3168/jds.s0022-0302(95)76659-0
Hessle C., Andersson B., Wold A. E., Gram-Positive Bacteria Are Potent Inducers of Monocytic Interleukin-12 (IL-12) while Gram-Negative Bacteria Preferentially Stimulate IL-10 Production, 10.1128/iai.68.6.3581-3586.2000
Kleerebezem M., Boekhorst J., van Kranenburg R., Molenaar D., Kuipers O. P., Leer R., Tarchini R., Peters S. A., Sandbrink H. M., Fiers M. W. E. J., Stiekema W., Lankhorst R. M. K., Bron P. A., Hoffer S. M., Groot M. N. N., Kerkhoven R., de Vries M., Ursing B., de Vos W. M., Siezen R. J., Complete genome sequence of Lactobacillus plantarum WCFS1, 10.1073/pnas.0337704100
Morath Siegfried, Geyer Armin, Hartung Thomas, Structure–Function Relationship of Cytokine Induction by Lipoteichoic Acid fromStaphylococcus aureus, 10.1084/jem.193.3.393
Morath S., Structural Decomposition and Heterogeneity of Commercial Lipoteichoic Acid Preparations, 10.1128/iai.70.2.938-944.2002
Morath Siegfried, Stadelmaier Andreas, Geyer Armin, Schmidt Richard R., Hartung Thomas, Synthetic Lipoteichoic Acid fromStaphylococcus aureusIs a Potent Stimulus of Cytokine Release, 10.1084/jem.20020322
Opitz Bastian, Schröder Nicolas W. J., Spreitzer Ingo, Michelsen Kathrin S., Kirschning Carsten J., Hallatschek Werner, Zähringer Ulrich, Hartung Thomas, Göbel Ulf B., Schumann Ralf R., Toll-like Receptor-2 MediatesTreponemaGlycolipid and Lipoteichoic Acid-induced NF-κB Translocation, 10.1074/jbc.m010481200
Schröder Nicolas W. J., Morath Siegfried, Alexander Christian, Hamann Lutz, Hartung Thomas, Zähringer Ulrich, Göbel Ulf B., Weber Joerg R., Schumann Ralf R., Lipoteichoic Acid (LTA) ofStreptococcus pneumoniaeandStaphylococcus aureusActivates Immune Cells via Toll-like Receptor (TLR)-2, Lipopolysaccharide-binding Protein (LBP), and CD14, whereas TLR-4 and MD-2 Are Not Involved, 10.1074/jbc.m212829200
Sherman, Applied and Environmental Microbiology, 52, 302 (1986)
Granato, Applied and Environmental Microbiology, 65, 1071 (1999)
CLIN DIAGN LAB IMMUNOL, 10, 259 (2003)
Chen Jau-Der, Morrison Donald A., Construction and properties of a new insertion vector, pJDC9, that is protected by transcriptional terminators and useful for cloning of DNA from Streptococcus pneumoniae, 10.1016/0378-1119(88)90489-1
ODONTOL REV, 18, 173 (1967)
Muller-Alouf H., Proft T., Zollner T. M., Gerlach D., Champagne E., Desreumaux P., Fitting C., Geoffroy-Fauvet C., Alouf J. E., Cavaillon J.-M., Pyrogenicity and Cytokine-Inducing Properties of Streptococcus pyogenes Superantigens: Comparative Study of Streptococcal Mitogenic Exotoxin Z and Pyrogenic Exotoxin A, 10.1128/iai.69.6.4141-4145.2001
Wallace John L., MacNaughton Wallace K., Morris Gerald P., Beck Paul L., Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease, 10.1016/0016-5085(89)90760-9
Ameho C K, Adjei A A, Harrison E K, Takeshita K, Morioka T, Arakaki Y, Ito E, Suzuki I, Kulkarni A D, Kawajiri A, Yamamoto S, Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis, 10.1136/gut.41.4.487
Archibald, Advances in carbohydrate chemistry and biochemistry, 21, 323 (1966)
NEUHAUS FRANCIS C., HEATON MICHAEL P., DEBABOV DMITRI V., ZHANG QUNYING, ThedltOperon in the Biosynthesis ofd-Alanyl-Lipoteichoic Acid inLactobacillus casei, 10.1089/mdr.1996.2.77
Rakoff-Nahoum Seth, Paglino Justin, Eslami-Varzaneh Fatima, Edberg Stephen, Medzhitov Ruslan, Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis, 10.1016/j.cell.2004.07.002
Travassos Leonardo H, Girardin Stephen E, Philpott Dana J, Blanot Didier, Nahori Marie-Anne, Werts Catherine, Boneca Ivo G, Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition, 10.1038/sj.embor.7400248
Watanabe Tomohiro, Kitani Atsushi, Murray Peter J, Strober Warren, NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses, 10.1038/ni1092
Lammers Karen Manon, Brigidi Patrizia, Vitali Beatrice, Gionchetti Paolo, Rizzello Fernando, Caramelli Elisabetta, Matteuzzi Diego, Campieri Massimo, Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells, 10.1016/s0928-8244(03)00144-5
Rachmilewitz Daniel, Katakura Kyoko, Karmeli Fanny, Hayashi Tomoko, Reinus Constantin, Rudensky Bernard, Akira Shizuo, Takeda Kiyoshi, Lee Jongdae, Takabayashi Kenji, Raz Eyal, Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis, 10.1053/j.gastro.2003.11.019
Reid Gregor, Guarner Francisco, Gibson Glenn, Tompkins Thomas, Gill Harsharn, Rowland Ian, Rastall Bob, Pot Bruno, Sanders Mary Ellen, Discussion on toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis, 10.1053/j.gastro.2004.05.052
Steidler L., Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10, 10.1126/science.289.5483.1352
Bibliographic reference
Grangette, C ; Nutten, S ; Palumbo, E ; Morath, S ; Hermann, C ; et. al. Enhanced anti inflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. In: Proceedings of the National academy of sciences of the United States of America, Vol. 102, no. 29, p. 10321-10326 (2005)